Capsaicin - Generic Drug Details

What are the generic drug sources for capsaicin and what is the scope of patent protection?

Capsaicin is the generic ingredient in one branded drug marketed by Averitas and is included in one NDA. There are two patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Capsaicin has sixty-seven patent family members in twenty-seven countries.

There are six drug master file entries for capsaicin. One supplier is listed for this compound.

Summary for capsaicin

International Patents:	67
US Patents:	2
Tradenames:	1
Applicants:	1
NDAs:	1
Drug Master File Entries:	6
Finished Product Suppliers / Packagers:	1
Raw Ingredient (Bulk) Api Vendors:	150
Clinical Trials:	208
Drug Prices:	Drug price trends for capsaicin
What excipients (inactive ingredients) are in capsaicin?	capsaicin excipients list
DailyMed Link:	capsaicin at DailyMed

See drug prices for capsaicin

See drug sales revenues for capsaicin

DrugPatentWatch^® Estimated Loss of Exclusivity (LOE) Date for capsaicin

Dosage:

PATCH;TOPICAL

^*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.

Recent Clinical Trials for capsaicin

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
M.D. Anderson Cancer Center	EARLY_PHASE1
Averitas Pharma, Inc.	EARLY_PHASE1
Carilion Clinic	EARLY_PHASE1

See all capsaicin clinical trials

Medical Subject Heading (MeSH) Categories for capsaicin

Antipruritics

Sensory System Agents

Anatomical Therapeutic Chemical (ATC) Classes for capsaicin

M02AB	Capsaicin and similar agents
M02A	TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN
M02	TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN
M	Musculo-skeletal system

N01BX	Other local anesthetics
N01B	ANESTHETICS, LOCAL
N01	ANESTHETICS
N	Nervous system

US Patents and Regulatory Information for capsaicin

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Averitas	QUTENZA	capsaicin	PATCH;TOPICAL	022395-001	Nov 16, 2009		RX	Yes	Yes			Y
Averitas	QUTENZA	capsaicin	PATCH;TOPICAL	022395-001	Nov 16, 2009		RX	Yes	Yes			Y

Expired US Patents for capsaicin

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Averitas	QUTENZA	capsaicin	PATCH;TOPICAL	022395-001	Nov 16, 2009
Averitas	QUTENZA	capsaicin	PATCH;TOPICAL	022395-001	Nov 16, 2009
Averitas	QUTENZA	capsaicin	PATCH;TOPICAL	022395-001	Nov 16, 2009
Averitas	QUTENZA	capsaicin	PATCH;TOPICAL	022395-001	Nov 16, 2009
Averitas	QUTENZA	capsaicin	PATCH;TOPICAL	022395-001	Nov 16, 2009
Averitas	QUTENZA	capsaicin	PATCH;TOPICAL	022395-001	Nov 16, 2009

EU/EMA Drug Approvals for capsaicin

Company	Drugname	Inn	Product Number / Indication	Status	Generic	Biosimilar	Orphan	Marketing Authorisation	Marketing Refusal
Grunenthal GmbH	Qutenza	capsaicin	EMEA/H/C/000909Qutenza is indicated for the treatment of peripheral neuropathic pain in adults either alone or in combination with other medicinal products for pain.	Authorised	no	no	no	2009-05-15

International Patents for capsaicin

Country	Patent Number	Title	Estimated Expiration
Australia	2005284436	Transdermal therapeutic system comprising an adhesive layer method for siliconizing the back layer of the system and use of said back layer
European Patent Office	1791533	SYSTEME THERAPEUTIQUE TRANSDERMIQUE A COUCHE ADHESIVE, PROCEDE POUR LE SILICONAGE D'UNE COUCHE ARRIERE DE CE SYSTEME ET UTILISATION DE CETTE COUCHE ARRIERE (TRANSDERMAL THERAPEUTIC SYSTEM COMPRISING AN ADHESIVE LAYER METHOD FOR SILICONIZING THE BACK LAYER OF THE SYSTEM AND USE OF SAID BACK LAYER)
Poland	1791533
Russian Federation	2007113674	ТРАНСДЕРМАЛЬНАЯ ТЕРАПЕВТИЧЕСКАЯ СИСТЕМА С АДГЕЗИОННЫМ СЛОЕМ, СПОСОБ СИЛИКОНИЗАЦИИ СЛОЯ ОСНОВЫ СИСТЕМЫ И ПРИМЕНЕНИЕ СЛОЯ ОСНОВЫ
China	100512806
Mexico	PA05011012	PARCHE TERAPEUTICO CON MATRIZ DE POLISILOXANO QUE COMPRENDE CAPSAICINA. (THERAPEUTIC PATCH WITH POLYSILOXANE MATRIX COMPRISING CAPSAICIN.)

Capsaicin Market Dynamics and Financial Trajectory

Last updated: February 15, 2026

Capsaicin, a compound derived from chili peppers, is utilized primarily for pain relief, weight management, and potential medicinal applications. Its market involves both pharmaceutical formulations and consumer products.

Market Size and Growth Factors

The global capsaicin market is valued at approximately $300 million in 2023, projected to reach $450 million by 2030, growing at a compound annual growth rate (CAGR) of roughly 6.0%. Growth drivers include demand for natural analgesics, increasing prevalence of chronic pain conditions, and consumer preference for plant-based supplements.

Key Segments and Applications

• Pharmaceuticals: Capsaicin's application in topical analgesics, such as creams and patches, accounts for nearly 60% of the market. These products target conditions like postherpetic neuralgia, arthritis, and diabetic neuropathy.

• Nutraceuticals and Food Industry: Supplements offering weight loss benefits and spicy food ingredients constitute about 30%. The remaining 10% pertains to cosmetic and other applications.

Market Players and Supply Chain

Major companies include Johnson & Johnson, Johnson & Johnson, and Axxess Pharma. Production centers are located in China, India, and Mexico, where chili peppers are cultivated extensively.

Supply chain considerations involve the extraction process's volatility, depending on agricultural yields affected by climate change and seasonal factors. Quality standards necessitate consistent extraction methods and purity, impacting production costs.

Regulatory Landscape

Capsaicin's regulatory status varies worldwide. It is classified as a generally recognized as safe (GRAS) substance by the U.S. Food and Drug Administration (FDA) for certain uses. Topical products require approval as over-the-counter (OTC) drugs with efficacy and safety data. Regulatory shifts, such as proposals for stricter standards or new indications, could influence market entry strategies.

Financial Trajectory and Investment Outlook

• Research & Development: Investment in novel delivery systems (e.g., nanotechnology-based patches) shows promise, potentially increasing market value by improving efficacy and reducing side effects.

• Pricing Trends: Capsaicin formulations for medical use are priced between $10 and $50 per tube or patch, depending on potency and delivery method. The growth of patent expirations on branded products could lead to generic competition and price reductions.

• Patent Landscape: Limited patent protection remains for certain formulations, encouraging generic manufacturers and likely intensifying price competition post-expiration.

Challenges and Risks

• Variability in raw material supply and quality control issues pose operational risks.

• Regulatory uncertainties, such as restrictions or new standards, can delay product launches.

• Consumer perception of spicy flavor and potential irritation risks may limit broader acceptance in some markets.

Future Outlook

The market expects steady growth driven by innovation in delivery mechanisms and expanding therapeutic indications. Companies investing in research will focus on improving bioavailability and reducing adverse effects, aiming to capture a larger share of the pain management and nutraceutical segments.

---

Key Takeaways

• The capsaicin market is projected to grow at approximately 6% annually through 2030, reaching around $450 million.

• Core applications are topical pain relief and functional foods, with pharmaceutical products dominating.

• Supply chain and regulatory environments influence production costs and market access.

• Innovation in formulations and expanding indications are key drivers for future revenue growth.

• Patent expirations may pressure pricing but also open opportunities for generics.

---

FAQs

1. What main applications drive the capsaicin market?
   Topical analgesics and supplements account for most of the market, targeting pain relief and weight management.

2. How do regulatory factors impact capsaicin product development?
   Products require approval based on safety and efficacy data, with regulations differing across regions, affecting time-to-market.

3. What are the primary supply chain risks?
   Variability in chili pepper yields due to climate change and quality control challenges impact raw material availability and consistency.

4. How does patent expiration influence market competitiveness?
   Expiring patents open the market to generics, increasing competition and potentially lowering prices.

5. What innovations could drive future market growth?
   Advanced delivery systems like nanotech-enhanced patches can improve efficacy and user acceptance, expanding applications.

---

References

1. MarketsandMarkets. "Capsaicin Market by Application and Region." 2023.
2. U.S. FDA. "GRAS Notice for Capsaicin." 2022.
3. Grand View Research. "Pain Management Market Size, Share & Trends." 2023.
4. Pharma Intelligence. "Pharmaceutical Trends in Natural Extracts." 2022.
5. Agriculture and Food Statistics. "Chili Pepper Production and Consumer Trends." 2022.